Literature DB >> 21402661

Mild cognitive impairment and dementia in primary care: the value of medical history.

Javier Olazarán1, Pedro Torrero, Isabel Cruz, Esperanza Aparicio, Ana Sanz, Nieves Mula, Garbiñe Marzana, Dionisio Cabezón, Concepción Begué.   

Abstract

BACKGROUND: Primary care should be the place for the early detection of mild cognitive impairment (MCI) and dementia; however, a considerable proportion of these processes remain undetected at this setting. Family doctors may not have enough time or expertise for cognitive testing. The utility of clinical variables, other than cognitive tests, has hardly been investigated.
OBJECTIVES: To explore the diagnostic and prognostic value of the variables that are usually collected in the medical history of patients with suspected cognitive impairment.
METHODS: In this cohort study, people aged ≥ 50 years were prospectively searched for cognitive decline of unknown aetiology by seven primary care physicians (PCP) during their practice. The baseline assessment included demographic variables, symptom-related variables, medical and psychiatric co-morbidity, family history of dementia and neurological exam. The diagnosis was made by a neurologist at baseline and after 1 year.
RESULTS: One hundred and seventy-six patients were analysed of whom 81 (46.0%) had MCI and 18 (10.2%) had dementia at baseline. After 1 year, 8 (9.9%) MCI patients had progressed to dementia, but 48 (59.3%) had reverted to normal cognition. Old age, source of symptoms (informant or PCP), short duration and low education were associated with MCI or dementia at baseline; low education predicted progression to dementia in MCI patients and less chronic medical conditions and younger age predicted reversion from MCI to normal cognition (P < 0.05, adjusted regression models).
CONCLUSION: Clinical data usually collected on medical history by PCP are useful to detect patients with MCI and dementia and also to predict MCI outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21402661     DOI: 10.1093/fampra/cmr005

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  10 in total

1.  Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study.

Authors:  Hanna Kaduszkiewicz; Marion Eisele; Birgitt Wiese; Jana Prokein; Melanie Luppa; Tobias Luck; Frank Jessen; Horst Bickel; Edelgard Mösch; Michael Pentzek; Angela Fuchs; Sandra Eifflaender-Gorfer; Siegfried Weyerer; Hans-Helmut König; Christian Brettschneider; Hendrik van den Bussche; Wolfgang Maier; Martin Scherer; Steffi G Riedel-Heller
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

2.  Prevalence of potentially inappropriate prescriptions in primary care and correlates with mild cognitive impairment.

Authors:  Klejda Harasani; Delina Xhafaj; Anxhela Begolli; Maria C Olvera-Porcel
Journal:  Pharm Pract (Granada)       Date:  2020-08-22

3.  Clinical history for diagnosis of dementia in men: Caerphilly Prospective Study.

Authors:  Sam Creavin; Mark Fish; John Gallacher; Antony Bayer; Yoav Ben-Shlomo
Journal:  Br J Gen Pract       Date:  2015-08       Impact factor: 5.386

4.  A Real-Time Clinical Decision Support System, for Mild Cognitive Impairment Detection, Based on a Hybrid Neural Architecture.

Authors:  Carmen Paz Suárez-Araujo; Patricio García Báez; Ylermi Cabrera-León; Ales Prochazka; Norberto Rodríguez Espinosa; Carlos Fernández Viadero; For The Alzheimer's Disease Neuroimaging Initiative
Journal:  Comput Math Methods Med       Date:  2021-06-21       Impact factor: 2.238

5.  Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.

Authors:  Perminder S Sachdev; Darren M Lipnicki; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Wei Wen; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

6.  Clinical Predictors for Mild Cognitive Impairment Progression in a Korean Cohort.

Authors:  Yong S Shim; Dong Won Yang; Bora Yoon; Yunhwan Lee; Chang Hyung Hong; Sang Won Seo; Soo Jin Yoon; Jee Hyang Jeong; Moon Ho Park; Seong Hye Choi; Seong Yoon Kim
Journal:  Dement Neurocogn Disord       Date:  2016-10-18

Review 7.  Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations.

Authors:  Sam T Creavin; Susanna Wisniewski; Anna H Noel-Storr; Clare M Trevelyan; Thomas Hampton; Dane Rayment; Victoria M Thom; Kirsty J E Nash; Hosam Elhamoui; Rowena Milligan; Anish S Patel; Demitra V Tsivos; Tracey Wing; Emma Phillips; Sophie M Kellman; Hannah L Shackleton; Georgina F Singleton; Bethany E Neale; Martha E Watton; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2016-01-13

8.  Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment.

Authors:  Michael M Copenhaver; Victoria Sanborn; Roman Shrestha; Colleen B Mistler; Matthew C Sullivan; John Gunstad
Journal:  Drug Alcohol Depend       Date:  2021-04-24       Impact factor: 4.852

9.  Help-seeking preferences in the area of mild cognitive impairment: comparing family physicians and the lay public.

Authors:  Perla Werner; Jeremia Heinik; Shmuel Giveon; Dikla Segel-Karpas; Eliezer Kitai
Journal:  Clin Interv Aging       Date:  2014-04-09       Impact factor: 4.458

Review 10.  How to choose the most appropriate cognitive test to evaluate cognitive complaints in primary care.

Authors:  Jolien Janssen; Paula S Koekkoek; Eric P Moll van Charante; L Jaap Kappelle; Geert Jan Biessels; Guy E H M Rutten
Journal:  BMC Fam Pract       Date:  2017-12-16       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.